Nūhou
-
ʻO Retatrutide, he triple hormone receptor agonist, no ka mālama ʻana i ka momona - kahi hoʻāʻo hoʻokolohua maʻi II.
I kēia mau makahiki i hala iho nei, ua holomua ka holomua o ka mālama ʻana i ka momona a me ka maʻi diabetes type 2. Ma hope o ka GLP-1 receptor agonists (eg, Semaglutide) a me nā agonists ʻelua (eg, Tirzepatide), Reta...Heluhelu hou aku -
ʻO Tirzepatide kahi agonist receptor pālua
Introduction ʻO Tirzepatide, i hoʻomohala ʻia e Eli Lilly, he lāʻau peptide hou e hōʻike ana i kahi milestone i ka mālama ʻana i ka maʻi diabetes type 2 a me ka momona. ʻAʻole like me ka GLP-1 kuʻuna (glucagon-like peptide...Heluhelu hou aku -
MOTS-c: He Mitochondrial Peptide me nā Pono Ola Ola
ʻO MOTS-c (Mitochondrial Open Reading Frame o ka 12S rRNA Type-c) he peptide liʻiliʻi i hoʻopili ʻia e ka DNA mitochondrial i loaʻa i ka hoihoi ʻepekema nui i nā makahiki i hala. Ma ka maʻamau, m...Heluhelu hou aku -
BPC-157: He Peptide e puka mai ana i loko o ka hana hou ʻana o ka Tissue
ʻO BPC-157, pōkole no Body Protection Compound-157, he peptide synthetic i loaʻa mai kahi ʻāpana protein pale kūlohelohe i loaʻa i ka wai ʻōpū o ke kanaka. Hoʻokumu ʻia he 15 amino acids, ua h...Heluhelu hou aku -
He aha ka Tirzepatide?
ʻO Tirzepatide kahi lāʻau lapaʻau hou e hōʻike ana i kahi holomua nui i ka mālama ʻana i ka maʻi diabetes type 2 a me ka momona. ʻO ia ka mua ʻelua agonist o ka glucose-dependent insulinotropic polypept ...Heluhelu hou aku -
ʻO GHK-Cu Copper Peptide: He Molekula Nui no ka Hoʻoponopono a me ka Anti-Aging
ʻO Copper peptide (GHK-Cu) kahi mea bioactive me ka waiwai lapaʻau a me ka waiwai hoʻonaninani. Ua ʻike mua ʻia ʻo ia i ka makahiki 1973 e ka ʻAmelika ʻAmelika a me ka mea hoʻokalakupua ʻo Dr. Loren Pickart. ʻO ka mea nui, he tripe ...Heluhelu hou aku -
Nā hōʻailona a me ka waiwai lapaʻau o Tirzepatide injection
ʻO Tirzepatide kahi moʻolelo ʻelua agonist o ka GIP a me GLP-1 receptors, i ʻae ʻia no ka mālama glycemic i nā pākeke me ka maʻi maʻi type 2 a me ka hoʻokele paona lōʻihi i nā poʻe me ke kino ...Heluhelu hou aku -
Lawe mai ʻo Sermorelin i ka Manaolana Hou no ka Anti-Aging and Health Management
Ke hoʻomau nei ka noiʻi honua i ke olakino a me ka lōʻihi, kahi peptide synthetic i kapa ʻia ʻo Sermorelin e huki nui ana i ka nānā ʻana mai ke kaiāulu olakino a me ka lehulehu. ʻAʻole like me ka tra...Heluhelu hou aku -
He aha ka NAD + a no ke aha he koʻikoʻi loa ia no ke olakino a me ka lōʻihi?
ʻO NAD⁺ (Nicotinamide Adenine Dinucleotide) he coenzyme koʻikoʻi i loaʻa i loko o nā mea ola a pau, i kapa pinepine ʻia ʻo ka "mole mole o ka ikaika cellular." Lawe ia i nā kuleana he nui i ka ...Heluhelu hou aku -
Ua huki ʻo Semaglutide i ka manaʻo nui no kona pono i ka hoʻokele kaumaha
Ma ke ʻano he agonist GLP-1, hoʻohālikelike ia i nā hopena physiological o GLP-1 i hoʻokuʻu maoli ʻia i loko o ke kino. I ka pane ʻana i ka lawe ʻana i ka glucose, nā neurons PPG i loko o ka ʻōnaehana nūnū waena (CNS) a me nā L-cell i ka ...Heluhelu hou aku -
ʻO Retatrutide: He Hōkū Piʻi e hiki ke hoʻololi i ka momona a me ka mālama maʻi diabetes
I nā makahiki i hala iho nei, ua hōʻoia ka piʻi ʻana o nā lāʻau lapaʻau GLP-1 e like me semaglutide a me tirzepatide e hiki ke hoʻemi nui ʻia ke kaumaha me ka ʻole o ka hana ʻana. I kēia manawa, hoʻomohala ʻo Retatrutide, kahi triple receptor agonist ...Heluhelu hou aku -
Hoʻomaka ʻo Tirzepatide i kahi hoʻololi hou i ka mālama ʻana i ke kaumaha, e hāʻawi ana i ka manaʻolana no ka poʻe me ka momona
I nā makahiki i hala iho nei, ua hoʻomau ka piʻi ʻana o ka nui o ka nui o ka honua, me nā pilikia olakino pili e piʻi nui ana. ʻAʻole pili wale ka momona i ka helehelena akā hoʻonui pū i ka pilikia o ka cardiovascular ...Heluhelu hou aku